Related Experiment Video
Updated: Feb 18, 2026

07:00
Dual Effects of Melanoma Cell-derived Factors on Bone Marrow Adipocytes Differentiation
Published on: August 23, 2018
6.6K
Bone marrow adipocytes in haematological malignancies
Ewa Frączak1, Mateusz Olbromski2, Aleksandra Piotrowska2
1Department of Hematology, Blood Neoplasms and Bone Marrow Transplantation, Medical University, Wrocław, Poland.
Acta Histochemica
|November 18, 2017
Summary
Bone marrow adipocytes (BMAs) quantity and morphology were characterized in patients with hematological malignancies. Infiltrated bone marrow showed fewer BMAs, with quantity increasing with age and BMI.
Area of Science:
- Hematology
- Oncology
- Cell Biology
- Bone Marrow Microenvironment
Background:
- Bone marrow adipocytes (BMAs) are crucial components of the bone marrow microenvironment, influencing metabolic functions and cellular interactions.
- BMAs play a role in tumor development and progression, yet their specific role in hematological malignancies is under-researched.
- Understanding BMA characteristics in these conditions is essential for elucidating disease mechanisms and potential therapeutic targets.
Purpose of the Study:
- To characterize the quantity and morphology of bone marrow adipocytes (BMAs) in patients with myeloproliferative and lymphoproliferative malignancies.
- To investigate the correlation between BMA parameters and clinical factors such as age, sex, BMI, and bone marrow infiltration.
- To compare BMA characteristics between patients with and without bone marrow infiltration, and between different types of hematological malignancies.
Main Methods:
- Analysis of trepanobioptate samples from 30 patients (17 myeloproliferative, 13 lymphoproliferative malignancies).
- Quantification of BMAs (number and diameter), adipocyte fraction (AF), hematopoietic fraction (HF), and trabecular bone fraction (BF).
- Correlation analysis with clinical parameters including age, sex, body weight, BSA, and BMI.
Main Results:
- Bone marrow infiltration was associated with a significantly decreased number of BMAs per mm² compared to non-infiltrated marrow.
- In infiltrated marrow, BMA number increased with age, and BMA diameter and AF increased with BMI.
- No significant correlation was found between BMA parameters and weight, BMI, BSA, or sex; BMA characteristics did not significantly differ between myeloproliferative and lymphoproliferative malignancies.
Conclusions:
- Bone marrow infiltration in hematological malignancies is associated with reduced BMA quantity, particularly in men.
- Age and BMI are significant factors influencing BMA quantity and morphology in infiltrated bone marrow.
- Further research is needed to fully elucidate the role of BMAs in the pathogenesis and progression of hematological malignancies.
Related Concept Videos
Bone Marrow Sampling and Transplants
1.5K
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
1.5K
Overview of Hematopoiesis
10.0K
Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
10.0K
Hematopoiesis
9.2K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
9.2K
Regulation of Hematopoietic Stem Cells
4.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
4.2K

